Dennis McBride - 13 Jun 2024 Form 3 Insider Report for NRX Pharmaceuticals, Inc. (NRXP)

Role
Director
Signature
/s/ Dennis McBride
Issuer symbol
NRXP
Transactions as of
13 Jun 2024
Net transactions value
$0
Form type
3
Filing time
26 Jun 2024, 19:37:40 UTC
Next filing
10 Sep 2025
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding NRXP Stock Options (Right to buy) 13 Jun 2024 Common Stock 6,320 $15.30 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 4,336 of the stock options were fully vested as of the date of this Form 3, with the remainder vesting in two equal installments on each of June 14, 2025 and June 14, 2026.